Obesity Clinical Trial
Official title:
An Experimental Medicine Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food in Healthy Volunteers
GSK is planning to undertake two anti-obesity drug studies in the area of obesity. In addition to assessment by questionnaires, it would be of significant value to incorporate an objective non-interventional measure of cognitive or motivational processing associated with evaluating and responding to food stimuli. Obesity is associated with increased attentional bias to palatable foods. The aims of this protocol are two-fold, first to characterize Event Related Potentials (ERPs) of two common aspects of food stimuli relevant to eating disorders -presence of food and its palatability, and secondly, to assess the modulation of these ERPs by appetite. Following a successful completion of this study, it is the intention to use the paradigm developed in future studies in the area of obesity.
GlaxoSmithKline is currently developing a number of drugs for the treatment of overheating
including 'binge eating' in obesity. Historically, the behavioural effectiveness of
anti-obesity drugs in clinical drug trials have utilised subjective rating scales to assess
a person's drive or motivation to eat. Findings from these studies have good construct
validity, but suffer from the shortcomings of self-reporting, e.g. the subject bias,
dishonesty, misinterpretation. It follows that in addition to self-reporting, it would
strengthen the interpretation of any future studies on anti-obesity drugs, if there were to
be an objective measure of brain activity in relation to cognitive/motivational processes
associated with evaluation and responding to food related cues.
Measuring event related potentials (ERPs) during cognitive processes of food related cues,
using the electroencephalography technique (EEG) offers a an alternative objective approach
to examining the effectives of anti-obesity drugs.
This protocol proposes to develop and use two cognitive tasks examining response to food
related cues (pictorial and words) with concurrent recording of ERPs, in order to
characterize neurophysiological events associated with attentional bias towards food related
stimuli.
The first task is an image processing task. This task uses food images similar to those in
the International Affective Picture System (IAPS) used in ERP studies of perceptual
processing of emotional stimuli [Olofsson, 2008; Schupp, 2006]. In this task a subject views
different categories of images; palatable high-calorie food images, non-palatable
low-calorie food images and non-edible plant images. The latter is the neutral category
against which the ERPs of the two food categories will be compared. Affective pictures have
been used to assess emotional valence by measuring differences in anterior ERP measurements
between images from differing groups.
The protocol also proposes to measure late positive potential in order to assess higher
level cognitive processing possibly with early memory formation. Again, the proposal is to
assess AUCs, in this case in the 400-600 ms region and then look at difference curves
between the late potential potentials to different valency stimuli. For the late positive
potentials, anterior laterality will also be assessed. The second task is a cued-target task
of visuospatial attention to motivationally salient words. The task is a version of the
Posner paradigm. The appearance of a food or nonfood word inside a top or bottom frame (the
cue) distracts the attention of the subject towards that spatial location. Following the
word either one of the two frames changes appearance (the target).
In addition to these emotion and attention measures, the protocol proposes to assess the
more standard N1, P1 and P3 [Luck, 2005]. After completing the ERP recordings the subject
will be asked to rate each picture for salience and valence in order to provide a comparison
between objective neurophysiological and subjective attention and emotional ratings.
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |